Cherry Tree Wealth Management’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
40,295
+19,824
+97% +$500K 0.19% 75
2026
Q1
$517K Buy
20,471
+909
+5% +$23.2K 0.11% 93
2025
Q4
$499K Buy
19,562
+3,004
+18% +$76.9K 0.11% 97
2025
Q3
$424K Buy
16,558
+4,285
+35% +$109K 0.09% 106
2025
Q2
$310K Buy
12,273
+3,541
+41% +$87.8K 0.07% 126
2025
Q1
$218K Buy
8,732
+2,320
+36% +$57.4K 0.05% 151
2024
Q4
$158K Buy
6,412
+395
+7% +$9.88K 0.04% 170
2024
Q3
$155K Buy
6,017
+2,112
+54% +$53.3K 0.04% 175
2024
Q2
$95.9K Hold
3,905
– – 0.02% 208
2024
Q1
$96.9K Buy
+3,905
New +$96.8K 0.02% 210

Other funds holding IBDX

Cherry Tree Wealth Management's IBDX Position: Q2 2026 in Review

Cherry Tree Wealth Management increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 97% in Q2 2026, buying an estimated $500K and bringing the position to 40,295 shares worth $1.02M. The position accounts for 0.19% of the portfolio, ranked #75.

Cherry Tree Wealth Management first reported a position in IBDX in Q1 2024 and has held it in 10 quarters since. 229 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Cherry Tree Wealth Management held 40,295 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $1.02M as of Q2 2026.
  • Cherry Tree Wealth Management bought 19,824 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $500K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.19% of Cherry Tree Wealth Management's portfolio in Q2 2026, its #75 holding.
  • Cherry Tree Wealth Management first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q1 2024 and has held it in 10 quarters since.
  • 229 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Cherry Tree Wealth Management's 13F filing for Q2 2026, filed 15 Sep 2026.